Tirzepatide has emerged as a groundbreaking treatment for who makes tirzepatides for Eli Lilly type 2 diabetes, offering promising results. However, the cost of this innovative drug and its access have become key issues for patients and healthcare practitioners. While tirzepatide has been approved by regulatory agencies, its costly nature presents